Form 8-K - Current report:
SEC Accession No. 0001193125-25-117771
Filing Date
2025-05-12
Accepted
2025-05-12 16:06:55
Documents
13
Period of Report
2025-05-12
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d52049d8k.htm   iXBRL 8-K 63359
  Complete submission text file 0001193125-25-117771.txt   184459

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rprx-20250512.xsd EX-101.SCH 2857
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE rprx-20250512_lab.xml EX-101.LAB 17236
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rprx-20250512_pre.xml EX-101.PRE 10817
16 EXTRACTED XBRL INSTANCE DOCUMENT d52049d8k_htm.xml XML 3557
Mailing Address 110 EAST 59TH STREET NEW YORK NY 10022
Business Address 110 EAST 59TH STREET NEW YORK NY 10022 (212) 883-0200
Royalty Pharma plc (Filer) CIK: 0001802768 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39329 | Film No.: 25934791
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)